The US label carries warnings about increases of suicidal behavior, major depressive disorder, and kidney failure. Adverse effects that caused people to stop taking the drug in clinical trials included diarrhea, nausea, depression, and anxiety. Potential adverse effects include headache, stomach pain, back pain, muscle pain, joint pain, chest pain, infections, flu-like symptoms, chills, heart palpitations, high blood pressure, fainting, vomiting, upset stomach, constipation, increased appetite, weight gain, edema, sleepiness, decreased sex drive, impotence, forgetfulness, abnormal thinking, abnormal vision, distorted sense of taste, tremors, runny nose, coughing, difficulty breathing, sore throat, bronchitis, and rashes.
Acamprosate
Retigabine
Tiagabine
Valproate
Felbamate
Domperidone
Pivagabine
Cenobamate